Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks
Notified -
Globe Newswire8-12-2025, 19:30
NTE Announces Closed Beta Test for 3 July During Livestream Showcase 23-06-2025, 20:00